Henry Schein (HSIC) is down more than -2% after reporting Q2 net sales of $3.10 billion, weaker than the consensus of $3.12 billion. Fed Governor Bowman said that "additional rate increases will likely be needed to get inflation on a path down to the FOMC's 2% target" to fully restore price stability. Moderna (MRNA) is down more than -6% to lead losers in the Nasdaq 100 after SVB Financial cut its price target on the stock to $68 from $82 and maintained its underperform rating.